Straumann Shares Retreat After Deutsche Bank Lowers Rating, Flags Multiple Risks
Shares of Swiss dental-technology firm Straumann slipped after Deutsche Bank downgraded the stock from buy to hold and trimmed its price target to CHF99 from CHF119. The bank highlighted a stretched valuation - roughly 26 times 2027 earnings - and several near-term risks, including inflation and rate pressures, possible weakness in China ahead of a…